What Is A Hematoma Medical Insights And Management

Published

Table of Contents

A hematoma represents a localized collection of blood outside blood vessels, often resulting from trauma, underlying medical conditions, or spontaneous vascular rupture. Unlike superficial bruises, hematomas can occur in deep tissues, organs, or cranial spaces, posing significant clinical challenges depending on their type, location, and severity. This condition spans a spectrum from benign subcutaneous accumulations to life-threatening intracranial hemorrhages, demanding precise diagnosis and tailored intervention. Understanding hematoma pathophysiology—from acute bleeding to chronic complications—is essential for clinicians, athletes, and individuals managing coagulopathies. Whether triggered by a sports injury, anticoagulant therapy, or congenital disorders, hematomas underscore the delicate balance between vascular integrity and systemic health.

The study of hematomas intersects with anatomy, hematology, and emergency medicine, revealing how disruptions in coagulation, vessel resilience, or mechanical forces precipitate pathological bleeding. From epidural hemorrhages in traumatic brain injury to muscle hematomas in weightlifters, each subtype presents unique diagnostic and therapeutic considerations. Advances in imaging and minimally invasive techniques have refined management strategies, yet misdiagnosis or delayed treatment can lead to irreversible complications such as compartment syndrome or neurological deficits. This exploration delves into the mechanisms, risk factors, and evidence-based approaches that define hematoma care, bridging theoretical knowledge with practical clinical application.

what's a hematoma

Definition and Medical Classification of a Hematoma

A hematoma represents a localized collection of blood outside the vascular system, resulting from disrupted blood vessel integrity and subsequent extravasation of blood into surrounding tissues or cavities. Unlike bruises (ecchymoses), which are superficial discolorations caused by minor capillary bleeding, hematomas involve larger vessel rupture and may accumulate in confined spaces, exerting mass effect. Differentiation from hemorrhages—where bleeding occurs within a body cavity or organ—lies in the hematoma’s contained nature, often forming a distinct mass. Pathophysiologically, hematomas arise from trauma, coagulopathic disorders, or iatrogenic interventions, with clinical severity correlating to size, location, and underlying vascular pathology.

Pathophysiological Mechanisms of Hematoma Formation

The development of a hematoma follows a sequence of vascular injury, hemostatic response, and tissue reaction. Vascular rupture initiates the process, whether due to blunt trauma (e.g., shearing forces in cerebral arteries), penetrating injuries, or pathological weakening (e.g., aneurysms). Coagulation failure, as seen in thrombocytopenia or anticoagulant therapy, impairs clot formation, prolonging bleeding. Increased vascular permeability (e.g., in vasculitis) or elevated blood pressure (e.g., hypertension) exacerbates extravasation. The resulting hematoma undergoes hemostasis (clot formation), inflammation (recruitment of macrophages and fibroblasts), and fibrosis (scar tissue formation), with chronic hematomas often encapsulating to form pseudocysts.

Key pathological stages:

  • Acute phase (0–3 days): Active bleeding and clot formation, with surrounding edema.
  • Subacute phase (3–10 days): Hemoglobin degradation (bilirubin formation), tissue necrosis.
  • Chronic phase (>10 days): Fibrous capsule development, potential calcification (e.g., in long-standing subdural hematomas).
    • Critical Factor: The mass effect of a hematoma—compression of adjacent structures—determines clinical urgency. For example, an epidural hematoma in the brain may cause herniation within hours, whereas a subcutaneous hematoma may resolve without intervention.

    Comparative Analysis: Acute vs. Chronic Hematomas

    Acute and chronic hematomas differ in etiology, timeline, and clinical presentation, with implications for diagnosis and management.
    FeatureAcute HematomaChronic Hematoma
    TimelineForms within minutes to hours post-injury.Develops over weeks to months; may rebleed.
    PathophysiologyPrimary vascular rupture; active bleeding.Secondary to hematoma expansion or coagulopathy. Often encapsulated.
    SymptomsRapid onset (e.g., headache, neurological deficits). Pain, swelling, or functional impairment.Insidious progression (e.g., chronic subdural in elderly). May present as mass effect or infection.
    Diagnostic ImagingHyperdense on CT (acute blood).Hypodense with peripheral enhancement (subacute/chronic).
    ComplicationsCompartment syndrome, herniation.Infection (e.g., abscess), calcification, or recurrent bleeding.
    TreatmentEmergent evacuation (e.g., craniotomy for epidural).Surgical drainage if symptomatic; conservative for asymptomatic.
    Example:
  • An acute subdural hematoma in a trauma patient may require urgent neurosurgical intervention due to midline shift, whereas a chronic subdural in an anticoagulated elderly patient might present with gradual cognitive decline and necessitate bur hole evacuation.

    • Classification of Hematomas by Location and Etiology

    Hematomas are categorized based on anatomical location and underlying cause, with distinct clinical implications.
    Type Location Primary Causes Key Symptoms
    Epidural Hematoma Between dura mater and skull (often temporal region).
    • Trauma (e.g., skull fracture rupturing middle meningeal artery).
    • Arteriovenous malformation (AVM).
    • Lucid interval followed by rapid deterioration (e.g., ipsilateral pupil dilation, hemiparesis).
    • Biconvex ("lentiform") shape on CT.
    Subdural Hematoma Between dura mater and arachnoid mater (bridging veins).
    • Trauma (even minor in elderly/coagulopathic patients).
    • Chronic alcoholism (atrophy stretches veins).
    • Acute: Headache, altered consciousness (e.g., GCS decline).
    • Chronic: Gradual confusion, seizures (months post-injury).
    Intracerebral Hematoma Within brain parenchyma (e.g., basal ganglia, lobar).
    • Hypertension (charcot-bouchard aneurysms).
    • Trauma, amyloid angiopathy (elderly).
    • Focal deficits (e.g., hemiplegia, aphasia).
    • Mass effect (e.g., hydrocephalus if ventricular compression).
    Subcutaneous Hematoma Within dermis/subcutaneous fat (e.g., forearm, thigh).
    • Blunt trauma (e.g., falls, sports injuries).
    • Coagulopathy (e.g., hemophilia, warfarin).
    • Pain, swelling, ecchymosis (color progression: red → blue → green).
    • Compartment syndrome if severe (e.g., forearm volar compartment).
    Retroperitoneal Hematoma Behind peritoneum (e.g., kidney, adrenal glands).
    • Trauma (e.g., pelvic fracture).
    • Anticoagulation, aortic aneurysm rupture.
    • Flank pain, hypotension (if >15% blood volume loss).
    • CT: High-density area displacing organs.
    Note: Spinal hematomas (e.g., epidural abscess, trauma) and muscle hematomas (e.g., quadriceps contusion) follow similar principles but require neurological monitoring due to spinal cord compression risks.

    Flowchart: Progression of a Hematoma from Injury to Complications

    The evolution of a hematoma follows a predictable yet variable trajectory, influenced by location, size, and host factors. Below is a structured progression:

    1. Initial Injury

  • Trigger: Trauma, coagulopathy, or vascular abnormality.
  • Outcome: Vessel rupture → acute bleeding into tissue/cavity.

    • 2. Acute Phase (0–72 Hours)

  • Pathology: Active hemorrhage; clot formation begins.
  • Clinical Features:
  • Pain, swelling, neurological deficits (if intracranial).
  • Mass effect (e.g., herniation in epidural hematoma).
  • Diagnosis: Imaging (CT/M

    • what's a hematoma - Ilustrasi 2

    Causes and Risk Factors of Hematomas

    Hematomas arise from the disruption of vascular integrity, leading to localized blood accumulation in tissues, organs, or body cavities. Their development is influenced by a combination of traumatic and non-traumatic factors, including mechanical forces, underlying medical conditions, and pharmacological interventions. Understanding these etiologies is critical for risk stratification, prevention, and targeted management strategies in clinical and occupational settings.

    The pathogenesis of hematomas involves either direct trauma—where external forces breach blood vessels—or spontaneous bleeding due to intrinsic abnormalities in coagulation, vascular fragility, or systemic disorders. Traumatic causes often correlate with high-impact activities, while non-traumatic etiologies frequently stem from predisposing conditions that impair hemostasis. Below, the primary mechanisms are categorized by their origin, followed by an analysis of high-risk activities, medication-related risks, and illustrative case studies.

    Traumatic Causes and External Forces

    Traumatic hematomas result from physical disruption of blood vessels, with severity depending on the force applied, vessel size, and tissue resilience. External forces can be classified into blunt trauma (e.g., falls, collisions) and penetrating trauma (e.g., lacerations, surgical incisions). Blunt trauma typically causes contusions or deep tissue hematomas, while penetrating injuries may lead to arterial or venous bleeding, increasing the risk of compartment syndrome or hemorrhage.

    Key mechanisms include:

  • Shear forces (e.g., whiplash injuries) that stretch vessels beyond their elastic limits.
  • Compression (e.g., crush injuries) that ruptures capillaries and small arteries.
  • High-velocity impacts (e.g., motor vehicle accidents) that generate cavitation effects, exacerbating tissue damage.

    • In sports and occupational settings, repetitive microtrauma (e.g., shin splints in runners) can also accumulate, leading to delayed-onset hematomas. The following table summarizes common traumatic scenarios, their associated risk levels, and preventive strategies:

    Activity/Scenario Risk Level Preventive Measures
    Contact sports (e.g., boxing, rugby, American football) High (direct blows, falls, collisions)
    • Mandatory protective gear (e.g., helmets, mouthguards, padding).
    • Enforcement of safety protocols (e.g., no head-down tackles).
    • Regular medical screening for coagulation disorders.
    Heavy machinery operation (e.g., construction, logging) High (crush injuries, flying debris)
    • Use of machine guards and lockout-tagout procedures.
    • Personal protective equipment (PPE) including steel-toe boots and high-visibility clothing.
    • Training in emergency shutdown protocols.
    Motor vehicle accidents (occupants, pedestrians) Very High (shear forces, deceleration injuries)
    • Seatbelt and airbag utilization.
    • Helmet laws for motorcyclists and cyclists.
    • Road design improvements (e.g., guardrails, speed limits).
    Falls from height (e.g., construction, elderly individuals) Moderate to High (impact on skull, spine, or extremities)
    • Installation of fall arrest systems (e.g., harnesses, nets).
    • Non-slip flooring and handrails in high-risk areas.
    • Balance training for elderly populations.
    Penetrating injuries (e.g., glass shards, knives, bullets) Variable (depends on depth, vessel involvement)
    • Immediate pressure application to control bleeding.
    • Tetanus prophylaxis and wound cleaning.
    • Avoidance of high-risk behaviors (e.g., unprotected combat sports).

    Non-Traumatic Causes and Internal Factors

    Non-traumatic hematomas develop due to spontaneous bleeding from underlying pathological conditions that impair hemostasis. These include coagulation disorders, vascular abnormalities, and systemic diseases that alter platelet function or vessel integrity. The following categories outline the primary internal risk factors:

    1. Hemostatic Disorders

  • Inherited conditions: Hemophilia A/B (factor VIII/IX deficiency) or von Willebrand disease (vWD) lead to prolonged bleeding times.
  • Acquired deficiencies: Vitamin K deficiency (impairs factors II, VII, IX, X) or liver disease (reduces synthesis of clotting factors).
  • Thrombocytopenia: Low platelet counts (<50,000/µL) increase susceptibility to petechiae and spontaneous hematomas.

    • 2. Vascular Fragility

  • Connective tissue disorders: Ehlers-Danlos syndrome (type IV) or Marfan syndrome weaken vessel walls.
  • Aneurysms or arteriovenous malformations (AVMs): Predispose to rupture and hematoma formation.
  • Amyloidosis: Deposition of amyloid proteins in vessel walls reduces elasticity.

    • 3. Systemic Inflammatory and Infectious Processes

  • Vasculitis (e.g., Henoch-Schönlein purpura) causes inflammation and microvascular leakage.
  • Sepsis: Disseminated intravascular coagulation (DIC) leads to widespread clotting and bleeding.
  • HIV/AIDS: Thrombocytopenia or coagulopathy from opportunistic infections.

    • 4. Neoplastic and Metabolic Conditions

  • Leukemia: Blasts infiltrate bone marrow, suppressing platelet production.
  • Diabetes mellitus: Microangiopathy weakens capillaries, increasing bruising risk.
  • Uremia: Chronic kidney disease impairs platelet function.

    • Medication-Induced Hematoma Risk

    Pharmacological agents that alter hemostasis significantly increase the likelihood of hematomas, particularly in patients with preexisting risks. The mechanisms include platelet inhibition, coagulation pathway disruption, or vascular effects. Key classes of high-risk medications are detailed below, along with their pathophysiological impacts:

    - Antiplatelet Agents

  • Aspirin: Irreversibly inhibits cyclooxygenase (COX-1), reducing thromboxane A2 and platelet aggregation.
  • Clopidogrel/Prasugrel: ADP receptor antagonists that prevent GPIIb/IIIa activation.
  • Risk: Increased risk of GI hematomas, epidural/spinal hematomas (post-spinal puncture), and intracranial bleeds.

    • - Anticoagulants

  • Warfarin: Vitamin K antagonist that depletes factors II, VII, IX, and X.
  • Direct oral anticoagulants (DOACs): Rivaroxaban, apixaban inhibit factor Xa; dabigatran targets thrombin.
  • Risk: Spontaneous hematomas in soft tissues (e.g., thigh, abdomen) or retroperitoneal bleeds, which may present as hypotension or flank pain.

    • - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

  • Ibuprofen/Naproxen: Inhibit COX-1/2, reducing prostaglandins that protect gastric mucosa and promote platelet function.
  • Risk: Gastrointestinal hematomas (e.g., gastric ulcers with bleeding) and renal papillary necrosis (leading to hematuria).

    • - Corticosteroids

  • Prednisone/Dexamethasone: Suppress immune-mediated vascular inflammation but also impair wound healing and collagen synthesis.
  • Risk: Delayed hematoma resolution and skin fragility, increasing bruising with minor trauma.

    • - Chemotherapeutic Agents

  • Cytarabine, Gemcitabine: Induce thrombocytopenia or disseminated intravascular coagulation (DIC).
  • Risk: Spontaneous intracerebral or pulmonary hematomas, particularly in patients with preexisting coagulopathies.

    • Case Study: Spontaneous Retroperitoneal Hematoma in a Patient with Liver Disease

    Patient History:
    A 62-year-old male with cirrhosis secondary

    Symptoms and Diagnostic Methods in Hematomas

    Hematomas manifest through a spectrum of clinical presentations, ranging from asymptomatic findings to life-threatening complications, depending on their location, size, and underlying etiology. Accurate diagnosis requires a systematic approach integrating patient history, physical examination, and advanced imaging techniques. This section outlines the characteristic symptoms by anatomical region and severity, alongside diagnostic modalities tailored to differentiate hematoma types, progression, and associated complications.

    Symptoms of Hematomas by Location and Severity

    Symptoms vary significantly based on the anatomical site and extent of bleeding. Below is a structured checklist organized by location and severity, with mild symptoms progressing to critical indicators requiring urgent intervention.
    Location Mild Symptoms Moderate Symptoms Severe/Life-Threatening Symptoms
    Head (Intracranial or Subgaleal)
    • Localized tenderness or swelling at the injury site.
    • Minimal headache or dizziness.
    • Mild confusion or transient memory lapses.
    • Persistent headache worsening over hours.
    • Vomiting (without nausea).
    • Slurred speech or focal neurological deficits (e.g., hemiparesis).
    • Seizures (in subdural hematomas).
    • Altered mental status (GCS < 13).
    • Fixed, dilated pupil (ipsilateral to mass effect).
    • Cushing’s triad (bradycardia, hypertension, irregular respirations).
    • Herniation signs (e.g., decerebrate posturing).
    Note: Subgaleal hematomas in infants may present as a rapidly expanding "caput succedaneum" with systemic signs of hypovolemia due to blood loss into the scalp.
    Abdominal (Retroperitoneal or Visceral)
    • Mild abdominal discomfort or fullness.
    • Minimal bruising (e.g., flank ecchymosis in renal hematomas).
    • No systemic instability.
    • Persistent or worsening abdominal pain.
    • Rebound tenderness or guarding.
    • Hematemesis or melena (if gastrointestinal source).
    • Hypotension or tachycardia (suggesting active bleeding).
    • Hemodynamic collapse (systolic BP < 90 mmHg).
    • Peritoneal signs (rigidity, absent bowel sounds).
    • Acute kidney injury (in retroperitoneal hematomas).
    • Compartment syndrome (if muscle involvement).
    Warning: Retroperitoneal hematomas (e.g., from aortic aneurysm rupture) may present late due to delayed tamponade effects, masking severity until catastrophic bleeding occurs.
    Muscle/Soft Tissue (e.g., Quadriceps, Forearm)
    • Localized swelling and ecchymosis (immediate bruising: red/purple).
    • Mild pain with palpation.
    • No functional impairment.
    • Progressive swelling with discoloration (blue-green → yellow over 7–14 days).
    • Pain at rest or with passive movement.
    • Palpable fluid-filled mass.
    • Mild compartment syndrome (paresthesia, tense compartment).
    • Severe pain with paralysis (e.g., Volkmann’s contracture in forearm).
    • Pulselessness or pallor distal to the hematoma.
    • Rhabdomyolysis (dark urine, elevated CK > 5× ULN).
    • Systemic inflammatory response (fever, leukocytosis).
    Key Insight: Bruising progression follows a predictable timeline: red/purple (0–2 days) → blue (2–5 days) → green (5–7 days) → yellow (7–14 days). Delayed or atypical color changes may indicate infection or underlying coagulopathy.
    Joint (e.g., Knee, Shoulder)
    • Effusion without joint instability.
    • Mild stiffness or reduced range of motion.
    • Hemarthrosis (bloody joint fluid).
    • Mechanical symptoms (locking, giving-way).
    • Synovial irritation (warmth, erythema).
    • Joint deformity or dislocation.
    • Chronic pain with degenerative changes (e.g., osteoarthritis).
    Clinical Pearl: Hemarthrosis in patients on anticoagulants (e.g., warfarin) may present with minimal trauma but rapid joint swelling, mimicking septic arthritis.

    Diagnostic Procedures for Hematomas

    Diagnostic accuracy hinges on selecting imaging modalities that distinguish hematoma age, location, and etiology. Each technique offers unique advantages and limitations, particularly in differentiating acute from chronic bleeding or identifying underlying vascular anomalies.
    Modality Advantages Limitations Differentiation Capabilities
    Computed Tomography (CT) Scan
    • Rapid acquisition (critical for acute hemorrhage).
    • High resolution for bone/soft tissue interfaces.
    • Quantifiable hematoma density (Hounsfield units):
      • Acute (<72h):

        what's a hematoma - Ilustrasi 3

        Treatment Approaches and Management of Hematomas

        The management of hematomas requires a tailored approach that balances conservative measures with interventional strategies, depending on the hematoma’s size, location, and clinical impact. Conservative methods prioritize non-invasive techniques to promote healing, while interventional approaches address complications such as infection, compartment syndrome, or persistent functional impairment. Evidence-based guidelines further refine treatment protocols for vulnerable populations, ensuring safety and efficacy across diverse anatomical and physiological contexts.

        Conservative Management Strategies

        Conservative treatment focuses on reducing swelling, alleviating pain, and preventing complications through non-surgical interventions. The RICE protocol (Rest, Ice, Compression, Elevation) remains a cornerstone for acute hematomas, particularly in soft tissues. Additional modalities, such as physical therapy and activity modification, play critical roles in restoring function without exacerbating injury.
        Method Indications Procedure Details Recovery Timeline
        RICE Protocol
        • Superficial hematomas (e.g., subcutaneous, intramuscular).
        • Acute traumatic hematomas (<72 hours old).
        • Mild to moderate pain without neurovascular compromise.
        • Rest: Avoid weight-bearing or aggravating activities for 24–72 hours.
        • Ice: Apply ice packs (10–15 minutes every 1–2 hours) for 48–72 hours to reduce edema and pain.
        • Compression: Use elastic bandages (e.g., ACE wraps) to limit swelling; avoid excessive tightness to prevent circulatory impairment.
        • Elevation: Elevate the affected limb above heart level for 20–30 minutes every 2–3 hours.
        • Initial improvement in swelling/pain within 48–72 hours.
        • Full resolution of superficial hematomas typically within 2–4 weeks.
        • Persistent symptoms beyond 1 week may require reassessment.
        Compression Therapy
        • Deep hematomas (e.g., thigh, calf) with risk of compartment syndrome.
        • Post-surgical hematomas to prevent seroma formation.
        • Apply graduated compression stockings or custom-fitted wraps (e.g., Unna boot for lower legs).
        • Monitor for signs of ischemia (pallor, paresthesia, pulselessness).
        • Combine with intermittent pneumatic compression (IPC) for venous stasis-related hematomas.
        • Reduction in swelling noticeable within 3–5 days.
        • Long-term use (weeks to months) for chronic edema or recurrent hematomas.
        Analgesics and Anti-Inflammatories
        • Moderate to severe pain associated with hematomas.
        • Inflammatory response in traumatic or post-surgical hematomas.
        • First-line: NSAIDs (e.g., ibuprofen 400–800 mg every 6–8 hours) for 5–7 days.
        • Opioids (e.g., tramadol, codeine) reserved for refractory pain or severe cases.
        • Avoid NSAIDs in patients with coagulopathies or renal impairment.
        • Pain relief typically within 24–48 hours of initiation.
        • Gradual tapering over 7–10 days to minimize rebound inflammation.
        Physical Therapy and Rehabilitation
        • Subacute hematomas (>72 hours old) with residual stiffness or weakness.
        • Joint or muscular hematomas (e.g., quadriceps, biceps) requiring mobility restoration.
        • Muscular Hematomas: Isometric exercises (e.g., quad sets, glute bridges) progress to eccentric loading (e.g., heel slides for hamstrings) once swelling subsides.
        • Joint Hematomas: Gentle range-of-motion (ROM) exercises (e.g., wrist circles, ankle pumps) followed by progressive resistance (e.g., theraband exercises).
        • Internal Hematomas (e.g., retroperitoneal): Core stabilization exercises (e.g., pelvic tilts) and gradual return to functional activities (e.g., walking, stair climbing).
        • Avoid direct massage over active hematomas to prevent rupture.
        • Initial phase (0–2 weeks): Focus on edema control and passive ROM.
        • Intermediate phase (2–6 weeks): Strengthening and proprioceptive training.
        • Advanced phase (6+ weeks): Sport-specific or occupation-specific rehabilitation.

        Interventional Management and Surgical Criteria

        Interventional approaches are reserved for hematomas that fail conservative management or pose immediate risks such as compartment syndrome, infection, or hemodynamic instability. Surgical intervention is guided by size thresholds, symptom severity, and anatomical location, with evidence-based guidelines prioritizing patient-specific factors.
        Intervention Indications Procedure Details Recovery Timeline
        Percutaneous Drainage
        • Deep hematomas (>5 cm diameter) in accessible locations (e.g., thigh, forearm).
        • Symptomatic seromas or expanding hematomas post-surgery.
        • Hematomas with systemic effects (e.g., hypotension from retroperitoneal bleed).
        • Ultrasound-guided aspiration using a large-bore needle (14–18 gauge) or catheter.
        • Evacuate clotted blood under sterile conditions; may require irrigation with saline.
        • Compression dressing applied post-procedure to prevent recurrence.
        • Immediate relief of pressure symptoms (e.g., pain, paresthesia).
        • Monitor for recurrence; repeat drainage may be needed if hematoma refills.
        • Full activity resumption typically within 1–2 weeks if no complications.
        Surgical Evacuation
        • Hematomas >10 cm in diameter or expanding despite drainage.
        • Compartment syndrome (e.g., elevated intracompartmental pressure >30 mmHg).
        • Anatomical locations with critical structures at risk (e.g., intracranial, spinal, or retroperitoneal).
        • Infection (e.g., abscess formation secondary to hematoma).
        • Open incision and drainage (I&D) under general or regional anesthesia.
        • Debridement of necrotic tissue if infection is present.
        • Suturing or wound packing for large defects; negative-pressure wound therapy (

          Hematomas exemplify the intersection of acute trauma and chronic disease, where early recognition and intervention can prevent severe morbidity. From the subtle discoloration of a contusion to the emergent signs of an expanding intracranial bleed, each presentation demands a systematic approach—balancing conservative measures like rest and compression with interventional strategies such as surgical evacuation or thrombolytics. The management of hematomas reflects broader trends in medicine: personalized risk assessment for patients on anticoagulants, proactive monitoring in high-risk professions, and adaptive rehabilitation for functional recovery. As research continues to unravel the genetic and environmental factors predisposing individuals to spontaneous hematomas, the field evolves toward predictive diagnostics and targeted therapies. Ultimately, hematomas serve as a critical reminder of the body’s vulnerability to vascular compromise, underscoring the importance of vigilance, education, and interdisciplinary collaboration in mitigating their impact.

          FAQ

          What is a hematoma during pregnancy, and how does it differ from normal pregnancy-related bruising?

          A hematoma during pregnancy is a localized collection of blood outside blood vessels, often caused by trauma, bleeding disorders, or complications like placental abruption. Unlike minor bruising, it can form in areas like the vaginal wall, vulva, or abdomen and may require medical attention if severe. Symptoms include pain, swelling, or visible discoloration, and it can sometimes indicate underlying issues like placental detachment.

          How can you tell what a hematoma looks like on the skin or under the surface?

          A hematoma typically appears as a raised, swollen, and discolored area, often with colors ranging from red/blue (fresh bleeding) to greenish-yellow/brown (healing). On the skin, it may feel firm or spongy to the touch, while deeper hematomas might cause localized pain, warmth, or a visible bulge without obvious surface bruising.

          What causes a hematoma in a dog, and how is it different from a regular bruise?

          A dog’s hematoma is a blood-filled swelling caused by trauma (e.g., bites, falls, or blunt force), bleeding disorders, or even minor injuries in animals prone to easy bruising (like older dogs). Unlike a bruise, which is usually flat and spreads, a hematoma often forms a distinct, sometimes fluctuant (fluid-filled) lump that may expand over time due to ongoing bleeding.

          Why does a hematoma sometimes develop after surgery, and what are the risks?

          Post-surgical hematomas occur when blood collects under the skin or in tissues due to bleeding from cut vessels, poor clotting, or excessive movement after surgery. Risks include delayed healing, infection, or pressure on nerves/muscles, which may require drainage or revision surgery. Symptoms like swelling, pain, or oozing should prompt medical evaluation.

          What does a hematoma on a dog’s ear look like, and how is it treated?

          A dog’s ear hematoma appears as a swollen, fluid-filled pocket (often resembling a "cauliflower ear") caused by trauma, scratching, or blood vessel damage. Treatment usually involves draining the blood, applying pressure bandages, and sometimes suturing the ear flap to prevent recurrence. Antibiotics may be needed if infection occurs.

          What is a hematoma in the eye, and what are the common causes?

          A hematoma in the eye, or subconjunctival hemorrhage, is bleeding between the white of the eye and the clear membrane covering it, often from minor trauma, straining (e.g., coughing), or bleeding disorders. It looks like a bright red patch but is usually harmless and resolves in 1–2 weeks without treatment, though severe cases may require evaluation for underlying issues.

          Leave a Comment

          Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.